Polimerbio
Medical devices, Biopolymer development, Biopolymers, Biodegradable polymers, Tailor-made, Polymers for medical devices.
Medical devices, Biopolymer development, Biopolymers, Biodegradable polymers, Tailor-made, Polymers for medical devices.
Diagnosis, Metabolomics, Lipidomics, Nonalcoholic steatohepatitis (NASH), Data science, Early diagnosis, R&D.
Advanced therapies, Cell therapy, Regenerative medicine, Manufacturing, CMO, Cell therapy medicinal products, HC016, Acute lung injury, Acute spinal cord injury, Medical devices, Dermo-cosmetics, Wound healing, Ulcers, Complex wounds, Chronic wounds, Skin care, Reoxcare, Histoessence, Wharton Gel Complex
Promotion centre, Entrepreneurship support.
Drug manufacturing, Clinical trial batches, Pilot batches, GMP.
Formal education, University, Engineering, Business studies, Gastronomy, Educational sciences, Humanities, University degrees, Master’s degrees, Doctorates, Higher education, Research and transfer, Vocational training, Own courses.
Drug development, Tumour stroma, Cancer diagnosis, Immunoconjugates (ADCs).
Biomarkers, Diagnostics, Monitoring, Cancer, Autoimmune diseases, Inflammation, Protein-protein interactions, Post-translational modifications
Zebrafish, Alternative Models, R&D Process, Preclinical Research, Toxicity Screening, Toxicity Assays, Efficacy Assays, 3 Rs Animal Research.
Digital transformation, Analytics, Innovation, Cloud Computing, Hybrid IT, Mobility, Cybersecurity, Outsourcing, SAP, Microsoft, Blockchain, AI, Quantum Computing, Electronic Health Records, Digital health